ADHD Research News

New ADHD research studies referenced in this week's ADHD in the News:

  • Chandrasekaran, Adithya Narayan, et al. “Dissociable Components of Attention Exhibit Distinct Neuronal Signatures in Primate Visual Cortex.” Science Advances 10, no. 5 (February 2, 2024): eadi0645. DOI: 10.1126/sciadv.adi0645.
    • Referenced in “Neuroscientists reveal how brain coordinates attention and eye movements (Medical Xpress, February 29, 2024)”
  • Elliott, Glen R., Adi Diner, and Einat Sitbon. “An Objective Assessment of Effect of Stimulants on Attention in Individuals With ADHD.” Journal of Attention Disorders 28, no. 4 (February 2024): 451-457. DOI: 10.1177/10870547231215285.
    • Referenced in “Eye-tracking assessments could be the future of ADHD treatment evaluation (PsyPost, February 27, 2024)”
  • Gupta, Priyanka, and Devarajan Sridharan. “Presaccadic Attention Does Not Facilitate the Detection of Changes in the Visual Field.” PLOS Biology 22, no. 1 (January 25, 2024): e3002485. DOI: 10.1371/journal.pbio.3002485.
    • Referenced in “Neuroscientists reveal how brain coordinates attention and eye movements (Medical Xpress, February 29, 2024)”

 


ADHD medication and risk of cardiovascular diseases

Commentary by CHADD PAB member Russell J. Schachar, MD, on Zhang et al. Attention-Deficit/Hyperactivity Disorder Medications and Long-Term Risk of Cardiovascular Diseases, JAMA Psychiatry, November 22, 2023.

 


Trends in Stimulant Prescription Fills Among Commercially Insured Children and Adults—United States, 2016-2021

Morbidity and Mortality Weekly Report, March 31, 2023
Centers for Disease Control and Prevention

Summary:

What is already known about this topic?

Prescriptions for stimulants, primarily used to treat attention-deficit/ hyperactivity disorder (ADHD), were increasing for adults before the COVID-19 pandemic. Policies enacted during the pandemic expanded access to prescription stimulants via telehealth.

What is added by this report?

The percentage of adolescent and adult females and adult males receiving prescription stimulant fills increased during 2016-2021, particularly during 2020-2021.

What are the implications for public health practice?

Growing recognition of ADHD in adults and increases in prescription stimulant fills raise questions about current adult ADHD care. Development of clinical recommendations for diagnosing and managing adult ADHD could help guide safe and appropriate stimulant prescribing. Evaluation of policies enacted during the pandemic could identify benefits and harms of those policies.

Go to Trends in Stimulant Prescription Fills Among Commercially Insured Children and Adults—United States, 2016-2021 

Recent Webinars For Professionals

Other Resources

Subscribe to our mailing list